BN Business News
Add your company to Business Communicator →

Business · 09/03/2001Updated: 10/17/2026 · 1 min read

FDA Reclassifies Home Uterine Activity Monitor for Women with Preterm Delivery History

Summary

The FDA has reclassified the Corometrics Model 770 Home Uterine Activity Monitoring System from Class III to Class II, special controls, for use in women with a previous preterm delivery to aid in preterm labor detection, and made it codified in the Code of Federal Regulations.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights

Business insights →